Press releases

Month Year

Email alerts

Jan 30, 2018

IN.PACT Admiral Demonstrates Consistent and Durable Outcomes in New Two-Year Japan Data and IN.PACT Global Critical Limb Ischemia Cohort Analysis

Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD

DUBLIN and LEIPZIG - January 30, 2018 - Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence supporting the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with new...
Jan 30, 2018

Medtronic and Philips Partner to Innovate in Lung Cancer Management

Healthcare Leaders Join to Streamline and Optimize the Management of Lung Nodules

DUBLIN and AMSTERDAM - January 30, 2018 - In a collective effort to improve the management of patients with lung nodules, Medtronic plc (NYSE: MDT) and Royal Philips (NYSE: PHG; AEX: PHIA) have...
Jan 30, 2018

Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region

DUBLIN and SHANGHAI - January 30, 2018 - Medtronic plc (NYSE:MDT) today announced that Alex Gu, previously Vice President, Regional Growth Initiatives, Greater China, and leader of Medtronic's...
Jan 26, 2018

Medtronic Launches IDE Study to Evaluate the Abre(TM) Venous Self-Expanding Stent System in Patients with Deep Venous Disease

Study to Enroll Subjects at up to 35 Sites Across the U.S. and Europe

DUBLIN - January 26, 2018 - Medtronic plc (NYSE: MDT) today announced the initiation of its investigational device exemption (IDE) study for the Abre(TM) venous self-expanding stent system. The...
Jan 24, 2018

Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique with the Endurant(TM) II/IIs Stent Graft System

Clinical Study to Investigate the Performance of the ChEVAR Technique in AAA Patients with Short Aortic Necks

DUBLIN - January 24, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of the ENCHANT (ENdurant CHEVAR New Indication Trial) study. The post-market, non-interventional, multi-center,...

Show per page